Across TCGA pan-cancer cohorts, LINC00941 RNA is linked to patient survival in 24 of 34 cancer types, making it the most broadly survival-associated LINC00941 data layer.
The strongest signal is observed in mesothelioma (MESO), where higher LINC00941 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC00941 expression acts as an unfavorable survival marker, although some lineages such as DLBC and SKCM show a favorable association.
MESO, KIRC, and UVM are the cancer types where LINC00941 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.